All Companies

LLYCongressional Stock Trades

Eli Lilly & Co.

Pharmaceutical Preparations

Congressional stock trades in Eli Lilly & Co. (LLY) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

53

Politicians Trading

22

Last Traded

Jul 10, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Michael A. RulliRAug 7, 2026Jan 2, 2026Buy$1,001 - $15,000+6.72%
Byron DonaldsRMay 13, 2026Apr 2, 2026Buy$1,001 - $15,000+23.23%
Byron DonaldsRMay 13, 2026Apr 2, 2026Buy$1,001 - $15,000+23.23%
David TaylorRMar 6, 2026Feb 26, 2026Buy$1,001 - $15,000+12.81%
David TaylorRSep 2, 2025Aug 14, 2025Buy$15,001 - $50,000+68.45%
David TaylorRSep 2, 2025Aug 14, 2025Buy$1,001 - $15,000+68.45%
Lisa C. McClainRAug 13, 2025Jul 10, 2025Buy$1,001 - $15,000+45.82%
Marjorie Taylor GreeneRMay 19, 2025May 14, 2025Buy$1,001 - $15,000+61.12%
Marjorie Taylor GreeneRMay 6, 2025May 5, 2025Buy$1,001 - $15,000+40.35%
Bruce WestermanRApr 16, 2025Mar 3, 2025Buy$1,001 - $15,000+24.01%
Marjorie Taylor GreeneRJan 27, 2025Jan 21, 2025Buy$1,001 - $15,000+55.31%

Price History

About Eli Lilly & Co.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.